APA (7th ed.) Citation

PB, J., T, V., S, S., F, J., G, W., G, L., . . . DF, M. (2025). Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled Trial. Gastroenterology, 168(4), 701. https://doi.org/10.1053/j.gastro.2024.11.023

Chicago Style (17th ed.) Citation

PB, Jeppesen, et al. "Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled Trial." Gastroenterology 168, no. 4 (2025): 701. https://doi.org/10.1053/j.gastro.2024.11.023.

MLA (9th ed.) Citation

PB, Jeppesen, et al. "Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled Trial." Gastroenterology, vol. 168, no. 4, 2025, p. 701, https://doi.org/10.1053/j.gastro.2024.11.023.